Mercer Global Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $949K | Sell |
11,444
-5,047
| -31% | -$419K | ﹤0.01% | 1221 |
|
2025
Q1 | $1.34M | Buy |
16,491
+3,751
| +29% | +$304K | ﹤0.01% | 990 |
|
2024
Q4 | $1.15M | Buy |
12,740
+1,651
| +15% | +$149K | ﹤0.01% | 1042 |
|
2024
Q3 | $1.09M | Sell |
11,089
-39
| -0.4% | -$3.83K | ﹤0.01% | 987 |
|
2024
Q2 | $1.03M | Buy |
11,128
+3,214
| +41% | +$298K | ﹤0.01% | 954 |
|
2024
Q1 | $749K | Buy |
7,914
+1,169
| +17% | +$111K | ﹤0.01% | 1083 |
|
2023
Q4 | $602K | Sell |
6,745
-120
| -2% | -$10.7K | ﹤0.01% | 1214 |
|
2023
Q3 | $501K | Sell |
6,865
-1,575
| -19% | -$115K | ﹤0.01% | 1251 |
|
2023
Q2 | $702K | Buy |
8,440
+435
| +5% | +$36.2K | ﹤0.01% | 1082 |
|
2023
Q1 | $610K | Sell |
8,005
-1,732
| -18% | -$132K | ﹤0.01% | 1105 |
|
2022
Q4 | $808K | Buy |
9,737
+2,622
| +37% | +$218K | ﹤0.01% | 1003 |
|
2022
Q3 | $564K | Buy |
7,115
+1,038
| +17% | +$82.3K | ﹤0.01% | 1078 |
|
2022
Q2 | $451K | Sell |
6,077
-3,934
| -39% | -$292K | ﹤0.01% | 1198 |
|
2022
Q1 | $900K | Buy |
10,011
+1,113
| +13% | +$100K | 0.01% | 940 |
|
2021
Q4 | $996K | Buy |
8,898
+60
| +0.7% | +$6.72K | 0.01% | 885 |
|
2021
Q3 | $1.11M | Sell |
8,838
-1
| -0% | -$126 | 0.01% | 812 |
|
2021
Q2 | $1.2M | Buy |
8,839
+665
| +8% | +$90.1K | 0.01% | 758 |
|
2021
Q1 | $1.11M | Buy |
8,174
+3,850
| +89% | +$523K | 0.01% | 748 |
|
2020
Q4 | $609K | Sell |
4,324
-696
| -14% | -$98K | 0.01% | 792 |
|
2020
Q3 | $559K | Buy |
5,020
+1,125
| +29% | +$125K | 0.01% | 753 |
|
2020
Q2 | $436K | Buy |
3,895
+357
| +10% | +$40K | 0.01% | 729 |
|
2020
Q1 | $274K | Sell |
3,538
-117
| -3% | -$9.06K | 0.01% | 839 |
|
2019
Q4 | $348K | Sell |
3,655
-1,550
| -30% | -$148K | 0.01% | 864 |
|
2019
Q3 | $396K | Buy |
5,205
+165
| +3% | +$12.6K | 0.01% | 783 |
|
2019
Q2 | $442K | Buy |
5,040
+1,024
| +25% | +$89.8K | 0.01% | 729 |
|
2019
Q1 | $364K | Buy |
+4,016
| New | +$364K | 0.01% | 756 |
|